Allergen Research Takes Aim At Peanut Allergies With $80M
San Mateo-based Allergen Research, which is developing desensitization treatments for food allergies, said Thursday that it has raised $80M in a Series B funding. The biopharmaceuticals firm said the funding goes towards a Phase 3 clinical trail of its lead product, aimed at treating peanut allergies. The funding was led by Foresite Capital, and also included Longitude Capital, Fidelity Management & Research Company, Aisling Capital, Adage Capital, RA Capital Management and Palo Alto Investors. Jim Tananbaum of Foresite and Stacey Seltzer of Aisling join the company's board with the funding.
posted on Friday, March 13, 2015
Related companies:
Allergen Research Corp
Related stories:
> Peanut Labs Acquired By e-Rewards
> Peanut Labs Cracks Open $3.2M
> Casetext Takes $12M To Apply AI To Legal Research
> Lam Research To Buy SEZ Group
> BEFORE Brands Bags $35M For High Tech Baby Food
silicontap.com Home